scholarly journals Hospitalization Costs for Endovascular and Surgical Treatment of Ruptured Aneurysms in the United States Are Substantially Higher Than Medicare Payments

2012 ◽  
Vol 33 (6) ◽  
pp. 1037-1040 ◽  
Author(s):  
W. Brinjikji ◽  
D.F. Kallmes ◽  
G. Lanzino ◽  
H.J. Cloft
Pneumonia ◽  
2020 ◽  
Vol 12 (1) ◽  
Author(s):  
Bisma Ali Sayed ◽  
Drew L. Posey ◽  
Brian Maskery ◽  
La’Marcus T. Wingate ◽  
Martin S. Cetron

Abstract Background While persons who receive immigrant and refugee visas are screened for active tuberculosis before admission into the United States, nonimmigrant visa applicants (NIVs) are not routinely screened and may enter the United States with infectious tuberculosis. Objectives We evaluated the costs and benefits of expanding pre-departure tuberculosis screening requirements to a subset of NIVs who arrive from a moderate (Mexico) or high (India) incidence tuberculosis country with temporary work visas. Methods We developed a decision tree model to evaluate the program costs and estimate the numbers of active tuberculosis cases that may be diagnosed in the United States in two scenarios: 1) “Screening”: screening and treatment for tuberculosis among NIVs in their home country with recommended U.S. follow-up for NIVs at elevated risk of active tuberculosis; and, 2) “No Screening” in their home country so that cases would be diagnosed passively and treatment occurs after entry into the United States. Costs were assessed from multiple perspectives, including multinational and U.S.-only perspectives. Results Under “Screening” versus “No Screening”, an estimated 179 active tuberculosis cases and 119 hospitalizations would be averted in the United States annually via predeparture treatment. From the U.S.-only perspective, this program would result in annual net cost savings of about $3.75 million. However, rom the multinational perspective, the screening program would cost $151,388 per U.S. case averted for Indian NIVs and $221,088 per U.S. case averted for Mexican NIVs. Conclusion From the U.S.-only perspective, the screening program would result in substantial cost savings in the form of reduced treatment and hospitalization costs. NIVs would incur increased pre-departure screening and treatment costs.


Orthopedics ◽  
2015 ◽  
Vol 38 (4) ◽  
pp. e281-e286 ◽  
Author(s):  
Dean Wang ◽  
Neal Berger ◽  
Jeremiah R. Cohen ◽  
Elizabeth L. Lord ◽  
Jeffrey C. Wang ◽  
...  

2019 ◽  
Vol 42 (7) ◽  
pp. 596-601 ◽  
Author(s):  
Aleksandr R. Bukatko ◽  
Parth B. Patel ◽  
Vindhya Kakarla ◽  
Matthew C. Simpson ◽  
Eric Adjei Boakye ◽  
...  

2019 ◽  
Vol 120 (6) ◽  
pp. 994-1007 ◽  
Author(s):  
Nathan H. Varady ◽  
Bishoy T. Ameen ◽  
Pierre‐Emmanuel Schwab ◽  
Caleb M. Yeung ◽  
Antonia F. Chen

2019 ◽  
Vol 1 (1) ◽  
pp. e59-e65
Author(s):  
Nicholas Bonazza ◽  
Dallas M. Smuin ◽  
Nicholas Sterling ◽  
Djibril Ba ◽  
Guodong Liu ◽  
...  

2020 ◽  
Vol 10 (5) ◽  
Author(s):  
Janani Rajbhandari‐Thapa ◽  
Justin B. Ingels ◽  
Sae R. Chung ◽  
Kiran Thapa ◽  
Zhuo Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document